Skip to main content
HomeNews

Photocure ASA: Annual general meeting held

Published: 5 May 2025Medical congresses & eventsFinancial Investment & Stock

Oslo, Norway, 5 May 2025: Photocure ASA (OSE: PHO), held its annual general meeting on 5 May 2025 at 17:00 hours (CEST).

The minutes from the general meeting setting out the resolutions are attached hereto.

 

For further information, please contact:

 

Photocure

CFO Erik Dahl

Tel: + 47 450 55 000

Email: ed@photocure.no

 

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com and www.cysview.com.

 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

News and events

OSE Notice
Photocure ASA: Results for the first quarter of 2025
Oslo, Norway
8 May 2025
OSE Notice
Photocure ASA: Annual general meeting held
Oslo, Norway
5 May 2025
OSE Notice
Photocure ASA: Invitation to presentation of first quarter 2025 financial results
Oslo, Norway
30 April 2025
PRESS-RELEASE
Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making
Oslo, Norway
29 April 2025
OSE Notice
Photocure ASA - Notice of the Annual General Meeting 5 May 2025
Oslo, Norway
11 April 2025
OSE Notice
Photocure ASA: Annual Report 2024
Oslo, Norway
11 April 2025
OSE Notice
Photocure ASA: Transactions made under share buyback program
Oslo, Norway
2 April 2025
OSE Notice
Photocure ASA: Transactions made under share buyback program
Oslo, Norway
31 March 2025
OSE Notice
Photocure ASA - Share option grant to Vice President and General Manager EMEA
Oslo, Norway
26 March 2025
PRESS-RELEASE
Photocure appoints Jane Healy as Vice President and General Manager EMEA
Oslo, Norway
26 March 2025
PRESS-RELEASE
Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer
Oslo, Norway
24 March 2025
OSE Notice
Photocure ASA: Initiation of a share buyback
Oslo, Norway
19 March 2025
PRESS-RELEASE
New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence
Oslo, Norway
14 March 2025
OSE Notice
Photocure ASA: Results for the fourth quarter of 2024
Oslo, Norway
19 February 2025
PRESS-RELEASE
News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC solution available in countries where System blue and Richard Wolf reusable flexible cystoscopes are cleared
Oslo, Norway
17 February 2025
PRESS-RELEASE
Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025
Oslo, Norway
17 February 2025